Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1791

0.0012

0.11%

GBP/USD

1.3216

0.0040

0.31%

USD/JPY

112.12

-0.9080

-0.80%

USD/CHF

0.9887

-0.0048

-0.49%

EUR/GBP

0.8921

-0.0022

-0.25%

USD/CAD

1.2772

0.0003

0.02%

NZD/USD

0.6813

-0.0042

-0.62%

EUR/JPY

132.20

-0.9325

-0.70%

EUR/CHF

1.1657

-0.0044

-0.38%

Cytori Therapeutics Inc

NASDAQ: CYTXWHealthcare / Biotechnology / USA
0.03+0.01+50.00%Vol 24 2361Y Perf -95.67%
Nov 17th, 2017 15:01
BID0.02 ASK0.03
Open0.02 Previous Close0.03
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
1.28 
Earnings Date

Today's Price Range

0.020.03

 

52wk Range

0.020.80

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-25.00%
3 Months
-40.00%
6 Months
-92.86%
1 Year
-95.67%
3 Years
-
5 Years
-98.24%
Last Quotes
Name / TickerPriceChg.Chg.%
CYTXW0.030.010050.00
AAPL170.15-0.9500-0.56
GOOG1 019.09-13.4100-1.30
MSFT82.40-0.8000-0.96
XOM80.24-0.3200-0.40
WFC54.15-0.4500-0.82
JNJ138.00-0.8700-0.63
FB179.00-0.5900-0.33
GE18.21-0.0400-0.22
JPM98.14-0.3300-0.34
...

TickerPriceChg.%52 Week High
FL40.8228.1679.43
VIAB26.1510.3846.72
ROST72.259.9973.94
GPS29.406.9930.14
FOX30.486.5731.94
FOXA31.156.2432.60
SWN6.455.7412.85
TGT58.145.5279.33
KR23.415.0736.44
RRC18.034.8339.64
DISCA17.554.7130.25
DISCK16.464.7129.18
ULTA215.104.44314.86
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.70
Current Ratio 1.20
Long Term Debt to Total Capital 0.41
Total Debt to Equity 1.29
Interest Coverage -8.90
Leverage Ratio 3.80
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin65.90
EBIT Margin-245.60
EBITDA Margin-226.60
Pre-tax Profit Margin-256.70
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-521.32
ROE last 12 Months -159.57
Return on Assets (5Y Avg) -73.68
ROA last 12 Months -63.59
Return on Capital (5Y Avg) -
ROC last 12 Months -69.81
Return on invested Capital Q -22.43
Return on invested Capital Y-65.72
Assets Turnover0.10
Receivables Turnover2.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)6 136
Revenue per Share -
Revenue Growth 3 Years 3.94
Revenue Growth 5 Years -4.77
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume24 236
Shares Outstanding (in ths.)0
Trades Count4
Dollar Volume511
Avg. Volume8 519
Avg. Weekly Volume28 617
Avg. Monthly Volume22 289
Avg. Quarterly Volume12 684

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x